The α/β subtype (CD3+, CD8+, TIA-1+, granzyme B+) has a favorable prognosis, while the γ/δ subtype (CD56+, CD4–, CD8–) is associated with hemophagocytic syndrome and worse outcomes [2,6,9,10,11]. The gene discussed is CD8A; the disease is hemophagocytic syndrome.